Curcumin in Alzheimer’s Disease: From Mechanistic Insights to Translational Challenges and Emerging Curcuminoid Strategies
Katarzyna Stępnik · 2026
Read Curcumin in Alzheimer’s Disease: From Mechanistic Insights to Translational Challenges and Emerging Curcuminoid Strategies by Katarzyna Stępnik (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13361446.txt.
Description
Katarzyna Stępnik reviews curcumin for Alzheimer's disease in a 2026 paper. Curcumin, the yellow compound in turmeric, is one of the most studied plant compounds for this brain disease. Alzheimer's grows from tangled causes: protein clumps, oxidative stress, inflammation, and failing cells. The review weighs lab, animal, and human evidence on how curcumin touches each cause.
Lab studies show curcumin calms inflammatory signals, fights oxidative stress, and slows clumping of the amyloid protein. Proof for effects on the tau protein is thinner. In animals, it improved thinking performance and lowered disease markers. The author then faces the hard part: turning strong lab promise into human benefit, given curcumin's poor absorption. New forms of the compound may help, and the review maps those strategies.
Catalog record
| CREATOR | Katarzyna Stępnik |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 77363 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |